Opportunities in Healthcare Investing
Barron's Live
00:00
Navigating the Healthcare Investment Landscape
This chapter explores the challenges of patient access to essential therapies, particularly for seniors, in the context of rising costs. It also highlights GLP-1 drugs and the potential of emerging biotech companies in addressing diseases like fatty liver and pneumonia amidst a competitive market landscape.
Transcript
Play full episode
